The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study to evaluate safety and preliminary efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in patients with locally advanced (LA) unresectable pancreatic ductal adenocarcinoma (PDAC).
 
Nadine Abi-Jaoudeh
Stock and Other Ownership Interests - Bruin Biosciences
Consulting or Advisory Role - AngioDynamics; AstraZeneca; Boston Scientific; Eisai; Genentech/Roche; Histosonics; innova vascular; Johnson & Johnson/CERENOVUS; Medtronic; QED Therapeutics; Sirtex Medical
Research Funding - ABK Y90 (Inst); AngioDynamics (Inst); BlackSwan Vascular (Inst); Guerbet (Inst); Impact Biotech Inc (Inst); Instylla (Inst); Sirtex Medical (Inst); Teclison (Inst); TriSalus Life Sciences (Inst); Varian Medical Systems (Inst)
 
Jennifer Brooke Valerin
Consulting or Advisory Role - AstraZeneca; Myriad Genetics
Speakers' Bureau - AstraZeneca
 
David K Imagawa
No Relationships to Disclose
 
Dina Preise
No Relationships to Disclose
 
Zachary Sacks
No Relationships to Disclose
 
Yaniv Cohen
No Relationships to Disclose
 
Julia Rothman
No Relationships to Disclose
 
Keren Brook
No Relationships to Disclose
 
Eyal Morag
No Relationships to Disclose
 
Avigdor Joshua Scherz
No Relationships to Disclose
 
Inna Krasnopolskaya
No Relationships to Disclose
 
Genia Alpert
No Relationships to Disclose
 
Vincent Chung
Consulting or Advisory Role - Perthera
Speakers' Bureau - AstraZeneca; Coherus Biosciences; Ipsen
Research Funding - Merck (Inst)
 
Laleh Golkar Melstrom
No Relationships to Disclose
 
Jonathan Kessler
Consulting or Advisory Role - Angiodynamics; AstraZeneca; Ethicon/Johnson & Johnson
Research Funding - Philips Healthcare